前往化源商城

573-34-2 靶点实验数据

HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:HepG2-CD81
External ID: CHEMBL4483864
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Science
Year: 2018
Volume: 362
Issue: 6419
DOI: 10.1126/science.aat9446

Target ChEMBL ID: CHEMBL4543887
ChEMBL Target Name: HepG2-CD81
ChEMBL Target Type: CELL-LINE - Target is a specific cell-line
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular

Data Source: Winzeler Lab Plasmodium Screening
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard Units
3.48HEPG2TOX ASSAY - CC90=3.48uM
1.05HEPG2TOX ASSAY - CC50=1.05uM
1.05HEPG2TOX ASSAY - CC90=1.05uM
6.54HEPG2TOX ASSAY - CC50=6.54uM
4.75HEPG2TOX ASSAY - CC90=4.75uM
1.63HEPG2TOX ASSAY - CC50=1.63uM
1.63HEPG2TOX ASSAY - CC90=1.63uM
7.48HEPG2TOX ASSAY - CC50=7.48uM
3.26HEPG2TOX ASSAY - CC90=3.26uM
0.0189HEPG2TOX ASSAY - CC50=0.0189uM
6.77HEPG2TOX ASSAY - CC90=6.77uM
7.54HEPG2TOX ASSAY - CC50=7.54uM
12.4HEPG2TOX ASSAY - CC90>12.4uM
6.3HEPG2TOX ASSAY - CC50=6.3uM
6.3HEPG2TOX ASSAY - CC90=6.3uM
9.05HEPG2TOX ASSAY - CC50=9.05uM
14.9HEPG2TOX ASSAY - CC90>14.9uM
12.7HEPG2TOX ASSAY - CC50>12.7uM
12.7HEPG2TOX ASSAY - CC90>12.7uM
8.37HEPG2TOX ASSAY - CC50>8.37uM
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:Plasmodium berghei
External ID: CHEMBL4483863
Protocol: N/A
Comment: Compounds with activity <= 10uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation.

Journal: Science
Year: 2018
Volume: 362
Issue: 6419
DOI: 10.1126/science.aat9446

Target ChEMBL ID: CHEMBL612653
ChEMBL Target Name: Plasmodium berghei
ChEMBL Target Type: ORGANISM - Target is a complete organism
Relationship Type: N - Non-molecular target assigned
Confidence: Target assigned is non-molecular

Data Source: Winzeler Lab Plasmodium Screening
PubChem Standard ValueStandard TypeStandard RelationStandard ValueStandard Units
9.56LUCIFERASE EXPRESSION CONTROL - IC90>9.56uM
1.17LUCIFERASE INFECTION ASSAY - IC50=1.17uM
1.41LUCIFERASE INFECTION ASSAY - IC90=1.41uM
10LUCIFERASE EXPRESSION CONTROL - IC50>10uM
9.72LUCIFERASE EXPRESSION CONTROL - IC90>9.72uM
9.01LUCIFERASE INFECTION ASSAY - IC50>9.01uM
9.01LUCIFERASE INFECTION ASSAY - IC90>9.01uM
9.01LUCIFERASE EXPRESSION CONTROL - IC50>9.01uM
9.01LUCIFERASE EXPRESSION CONTROL - IC90>9.01uM
8.99LUCIFERASE INFECTION ASSAY - IC50=8.99uM
10LUCIFERASE INFECTION ASSAY - IC90>10uM
10LUCIFERASE EXPRESSION CONTROL - IC50>10uM
9.81LUCIFERASE EXPRESSION CONTROL - IC90>9.81uM
3.23LUCIFERASE INFECTION ASSAY - IC50=3.23uM
6.33LUCIFERASE INFECTION ASSAY - IC90>6.33uM
6.33LUCIFERASE EXPRESSION CONTROL - IC50>6.33uM
8.74LUCIFERASE EXPRESSION CONTROL - IC90>8.74uM
10LUCIFERASE INFECTION ASSAY - IC50>10uM
10LUCIFERASE INFECTION ASSAY - IC90>10uM
10LUCIFERASE EXPRESSION CONTROL - IC50>10uM
HepG2 Cytotoxicity Assay Measured in Cell-Based System Using Plate Reader - 7071-02_Inhibitor_Dose_DryPowder_Activity_Set16
来源:ChEMBL 靶标:N/A
External ID: CHEMBL3301364
Protocol: N/A
Comment: Data Source: AstraZeneca DMPK/physicochemical
PubChem Standard ValueStandard TypeStandard ValueStandard Units
0.2Solubility200nM
0.1Solubility100nM
79.4Solubility79400nM
741.3Solubility741300nM
1445.4Solubility1445400nM
151.4Solubility151400nM
245.5Solubility245500nM
239.9Solubility239900nM
1445.4Solubility1445400nM
1445.4Solubility1445400nM
50.1Solubility50100nM
154.9Solubility154900nM
144.5Solubility144500nM
10.5Solubility10500nM
426.6Solubility426600nM
407.4Solubility407400nM
457.1Solubility457100nM
9.1Solubility9100nM
2.1Solubility2100nM
158.5Solubility158500nM